UltraGreen.ai (SGX:ULG) secured regulatory approvals for its Verdye injections systems in Malaysia and the Philippines, according to a Tuesday filing with the Singapore Exchange.
The fluorescence-guided surgery using indocyanine green injection has become an important tool across various surgical procedures.
Shares of the fluorescence-guided surgery and digital health solution company were up over 2% in Tuesday trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.